Related Experiment Videos

[Insulin resistance in kidney diseases]

V Spustová1, K Stefíková, L Hust'avová

  • 1Klinika farmakoterapie Ustavu preventívnej a klinickej medicíny, Bratislava.

Vnitrni Lekarstvi
|February 1, 1995
PubMed

Insights

Insulin resistance (IR) is common in kidney disease, impacting calcium and magnesium levels. Early diagnosis and treatment of IR are crucial for preventing kidney disease progression and reducing dialysis needs.

Area of Science:

  • Nephrology
  • Endocrinology
  • Metabolic Disorders

Context:

  • Insulin resistance (IR) is prevalent in various kidney diseases, affecting nearly half of patients with mild to moderate renal dysfunction and becoming nearly constant in advanced renal failure.
  • Specific features of IR in kidney disease include impaired calcitriol production even in early stages, potentially leading to secondary hyperparathyroidism and osteodystrophy if calcium intake is not increased or calcitriol not supplemented.
  • Renal IR involves altered intracellular calcium (Ca) and magnesium (Mg) concentrations, with increased free Ca and decreased free Mg.

Purpose:

  • To highlight the specific pathogenetic mechanisms of insulin resistance in kidney disease.
  • To emphasize the role of impaired calcitriol production, mineral imbalances (calcium and magnesium), and the renin-angiotensin system (RAS) in renal insulin resistance.
  • To underscore the importance of diagnosing, preventing, and treating insulin resistance as a key component in managing progressive nephropathies.

Summary:

  • Insulin resistance is a significant complication in kidney disease, characterized by impaired calcitriol metabolism, abnormal intracellular calcium and magnesium levels, and activation of the renin-angiotensin system.
  • Magnesium plays a critical role in glucose utilization, and its decline in renal disease exacerbates insulin resistance.
  • Early identification and management of IR are vital for mitigating the progression of kidney disease and potentially reducing the need for dialysis.

Impact:

  • Effective management of insulin resistance can significantly contribute to the comprehensive prevention of progressive nephropathies.
  • Addressing IR in kidney disease patients may lead to a substantial decrease in the number of patients requiring dialysis.
  • Integrated efforts from healthcare professionals are essential for implementing effective strategies for the diagnosis, prevention, and therapy of insulin resistance in nephropathic patients.

Related Concept Videos